Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Multiple Sclerosis

Free Subscription 29.06.2026 1 Acta Neuropathol 1 AJNR Am J Neuroradiol 1 Arch Phys Med Rehabil 2 BMC Neurol 1 J Neuroimmunol 2 J Neurol 1 J Neurol Sci 1 Lancet Neurol 3 Mult Scler 1 Neurology 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. LUTJE L, Chen JQA, Hamann J, Smolders J, et al
   Donor-specific pathological features associate with genetic background, lesion type distribution, and clinical heterogeneity in multiple sclerosis.
   Acta Neuropathol. 2026;151:72.
   PubMed         Abstract available
   
   

   
   AJNR Am J Neuroradiol

2. STORELLI L, Preziosa P, Tedone N, Gallo A, et al
   T1W/T2W Ratio to Assess Brain Microstructural Damage in Multiple Sclerosis: A Multicenter Study.
   AJNR Am J Neuroradiol. 2026 Jun 23:ajnr.A9488. doi: 10.3174/ajnr.A9488.
   PubMed         Abstract available
   
   

   
   Arch Phys Med Rehabil

3. AKKOC Y, Yildiz N, Adanur H, Tunc H, et al
   Neurogenic bowel dysfunction in multiple sclerosis: clinical determinants and its association with bladder dysfunction in a multicenter study.
   Arch Phys Med Rehabil. 2026 Jun 26:S0003-9993(26)00790.
   PubMed         Abstract available
   
   

   
   BMC Neurol

4. MAGHBOOLI Z, Nasir E, Mahdavinasab F, Sahraian MA, et al
   The HLA paradox across populations in multiple sclerosis progression: a systematic review.
   BMC Neurol. 2026 Jun 24. doi: 10.1186/s12883-026-05100.
   PubMed         Abstract available
   
   
5. FLINTERE-FLINTE A, Krutovs V, Pantelejeva E, Blennow K, et al
   Neurofilament light chain and glial fibrillary acidic protein as biomarkers of peripheral nervous system involvement in multiple sclerosis: diagnostic and prognostic evaluation.
   BMC Neurol. 2026 Jun 20. doi: 10.1186/s12883-026-05024.
   PubMed         Abstract available
   
   

   
   J Neuroimmunol

6. ABDULRIDHA GAO, Fadhel AS, Al-Kinany SQ, Makki NF, et al
   Serum IDO1 and beta-catenin levels in patients with multiple sclerosis with and without atherosclerosis: A case-control study.
   J Neuroimmunol. 2026;419:579013.
   PubMed         Abstract available
   
   

   
   J Neurol

7. GANGEMI E, Piervincenzi C, Tommasin S, Ojha A, et al
   The relationship between cerebellar functional connectivity alterations and hand dexterity impairment in multiple sclerosis.
   J Neurol. 2026;273:425.
   PubMed         Abstract available
   
   
8. MUNOZ-VENDRELL A, Arroyo-Pereiro P, Leon I, Bau L, et al
   Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis.
   J Neurol. 2026;273:412.
   PubMed         Abstract available
   
   

   
   J Neurol Sci

9. KARADENIZ M, Wesselingh R, Jayakrishnan PC, Sequeira RP, et al
   Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission.
   J Neurol Sci. 2026;488:126066.
   PubMed         Abstract available
   
   

   
   Lancet Neurol

10. LUNEMANN JD, Munz C
    Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies.
    Lancet Neurol. 2026 Jun 19:S1474-4422(26)00177.
    PubMed         Abstract available
    
    

    
    Mult Scler

11. AMATO MP, Portaccio E
    Cognitive impairment in multiple sclerosis: Where do we stand today?
    Mult Scler. 2026 Jun 23:13524585261457362. doi: 10.1177/13524585261457362.
    PubMed         Abstract available
    
    
12. LEE LE, Khoury M, Churchill N, Vavasour I, et al
    Cerebellar magnetization transfer ratio and its relationship to clinical outcomes in radiologically isolated syndrome and multiple sclerosis.
    Mult Scler. 2026 Jun 23:13524585261450926. doi: 10.1177/13524585261450926.
    PubMed         Abstract available
    
    
13. HUPPKE B, Reinert MC, Stark W, Gartner J, et al
    Serum neurofilament light chain in paediatric patients treated with natalizumab for highly active multiple sclerosis.
    Mult Scler. 2026 Jun 23:13524585261450816. doi: 10.1177/13524585261450816.
    PubMed         Abstract available
    
    

    
    Neurology

14. MIRCHI A, Vossough A, Liu GT, Narula S, et al
    Pearls & Oy-sters: Radiologic Lag in Pediatric-Onset Multiple Sclerosis.
    Neurology. 2026;107:e218254.
    PubMed         Abstract available
    
    

    
    PLoS One

15. JAKOB ER, Amireault S, Reed JB, Kao SC, et al
    Potential intervention targets to promote physical activity among people with multiple sclerosis: A scoping review protocol for evidence of moderation.
    PLoS One. 2026;21:e0351882.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum